Metraipolis › archive › dc_4e37436fd812

Concurrent pretreatment serum and BALF galactomannan positivity as a prognostic indicator in non-neutropenic invasive pulmonary aspergillosis without… — Europe PMC PMID:42210970

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42210970
DOI
10.3389/fmed.2026.1809671
License (as archived)
solo-consultazione
Archived
2026-11-02T10:53:41.562Z
SHA-256 of the archived text
955bdf2030126eaa15f56f0ebeb0a6e4ebb782ce20a41ba0ce9b5376c4636907
Stable URL of this page
https://metraipolis.com/documento/dc_4e37436fd812

How to cite

Concurrent pretreatment serum and BALF galactomannan positivity as a prognostic indicator in non-neutropenic invasive pulmonary aspergillosis without… — Europe PMC PMID:42210970 — Europe PMC (en), https://europepmc.org/article/MED/42210970 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4e37436fd812 (Metraipolis archive dc_4e37436fd812, sha256 955bdf2030126eaa15f56f0ebeb0a6e4ebb782ce20a41ba0ce9b5376c4636907)
BibTeX
@misc{dc4e37436fd812,
  title = {Concurrent pretreatment serum and BALF galactomannan positivity as a prognostic indicator in non-neutropenic invasive pulmonary aspergillosis without… — Europe PMC PMID:42210970},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42210970},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4e37436fd812; sha256 955bdf2030126eaa15f56f0ebeb0a6e4ebb782ce20a41ba0ce9b5376c4636907},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42210970. Agents can read the archived copy with the MCP tool read_document.